Idexx Laboratories (IDXX) Total Current Liabilities (2009 - 2026)

Idexx Laboratories' Total Current Liabilities history runs 18 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 14.4% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (up 14.4% YoY), while the FY2025 annual figure was $1.1 billion, up 7.58% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $1.3 billion, up from $1.1 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $1.3 billion in Q1 2026, with the low at $883.9 million in Q2 2023.
• The 5-year median for Total Current Liabilities is $1.1 billion (2024), against an average of $1.1 billion.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities jumped 87.73% in 2022, then decreased 24.23% in 2023.
• Idexx Laboratories' Total Current Liabilities stood at $1.2 billion in 2022, then declined by 23.0% to $951.5 million in 2023, then advanced by 12.23% to $1.1 billion in 2024, then gained by 7.58% to $1.1 billion in 2025, then gained by 13.15% to $1.3 billion in 2026.
• Business Quant data shows IDXX's Total Current Liabilities at $1.3 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.3 billion in Q3 2025.